Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial

BACKGROUND: Gene expression (GEX) signatures in breast cancer provide prognostic information, but little is known about their predictive value for tamoxifen treatment. We examined the tamoxifen-predictive value and prognostic effects of different GEX signatures in premenopausal women with early brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundgren, Christine, Tutzauer, Julia, Church, Sarah E., Stål, Olle, Ekholm, Maria, Forsare, Carina, Nordenskjöld, Bo, Fernö, Mårten, Bendahl, Pär-Ola, Rydén, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540453/
https://www.ncbi.nlm.nih.gov/pubmed/37773134
http://dx.doi.org/10.1186/s13058-023-01719-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540453/
https://www.ncbi.nlm.nih.gov/pubmed/37773134
http://dx.doi.org/10.1186/s13058-023-01719-z

Ejemplares similares